NCT00720304 2024-08-22Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and NeckCase Comprehensive Cancer CenterPhase 2 Completed43 enrolled 16 charts
NCT01414426 2021-01-14Vandetanib in Preventing Head and Neck Cancer in Patients With Precancerous Head and Neck LesionsUniversity of ChicagoPhase 2 Completed20 enrolled 7 charts